---
title: "Leukemia Clinical Trials in California"
description: "Find 67 clinical trials for leukemia near California. Connect with research centers in your area."
url: "https://www.clareohealth.com/clinical-trials/condition/leukemia/california"
---

# Leukemia Clinical Trials in California

Find 67 clinical trials for leukemia near California. Connect with research centers in your area.

- [All Leukemia trials nationwide](https://www.clareohealth.com/clinical-trials/condition/leukemia)
- [All trials in California](https://www.clareohealth.com/clinical-trials/location/california)

Showing 1-20 of 67 trials

### [Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation](https://www.clareohealth.com/clinical-trials/NCT04060277)

Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · NCT04060277 · Duarte, California · Sponsor: City of Hope Medical Center

This phase II trial studies how well Triplex vaccine works in preventing cytomegalovirus (CMV) infection in patients undergoing a hematopoietic stem cell transplantation.

### [Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant](https://www.clareohealth.com/clinical-trials/NCT01588015)

Status: COMPLETED · Phase: PHASE1 · NCT01588015 · Duarte, California · Sponsor: City of Hope Medical Center

This randomized phase I trial studies the side effects of vaccine therapy in preventing cytomegalovirus (CMV) infection in patients with hematological malignancies undergoing donor…

### [CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant](https://www.clareohealth.com/clinical-trials/NCT06059391)

Status: RECRUITING · Phase: PHASE2 · NCT06059391 · Duarte, California and 2 others · Sponsor: City of Hope Medical Center

This phase II clinical trial tests how well the cytomegalovirus-modified vaccinica Ankara (CMV-MVA) Triplex vaccine given to human leukocyte antigens (HLA) matched related stem cel…

### [S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer](https://www.clareohealth.com/clinical-trials/NCT00919425)

Status: COMPLETED · NCT00919425 · Fort Smith, Arkansas and 291 others · Sponsor: SWOG Cancer Research Network

RATIONALE: Collecting and storing samples of blood and bone marrow from patients with cancer to study in the laboratory may help doctors learn more about diagnosing cancer and how…

### [Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment](https://www.clareohealth.com/clinical-trials/NCT00066248)

Status: COMPLETED · Phase: PHASE2 · NCT00066248 · Oakland, California and 42 others · Sponsor: University of South Florida

RATIONALE: Cyproheptadine and megestrol may improve appetite and help prevent weight loss in children with cancer.

### [Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer](https://www.clareohealth.com/clinical-trials/NCT00301912)

Status: WITHDRAWN · Phase: PHASE2 · NCT00301912 · San Francisco, California · Sponsor: University of California, San Francisco

RATIONALE: Drugs used in chemotherapy, such as busulfan and fludarabine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them…

### [Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)](https://www.clareohealth.com/clinical-trials/NCT00185523)

Status: TERMINATED · NCT00185523 · Stanford, California · Sponsor: Stanford University

The purpose of the study is to evaluate the overall and disease free survival of recipients who have received G-CSF mobilized stem cells from HLA matched sibling donors.

### [Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies](https://www.clareohealth.com/clinical-trials/NCT01523223)

Status: COMPLETED · Phase: PHASE1 · NCT01523223 · Stanford, California · Sponsor: Robert Lowsky

This phase 1 trial studies the side effects and the best dose of donor CD8+ memory T-cells in treating patients with hematolymphoid malignancies.

### [Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)](https://www.clareohealth.com/clinical-trials/NCT02208037)

Status: COMPLETED · Phase: PHASE2 · NCT02208037 · Duarte, California and 29 others · Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Acute Graft-versus-Host-Disease (GVHD) is an important cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT).

### [Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases](https://www.clareohealth.com/clinical-trials/NCT00813501)

Status: TERMINATED · NCT00813501 · Duarte, California · Sponsor: City of Hope Medical Center

RATIONALE: Studying a diagnostic biomarker test in blood samples from patients who have undergone a donor stem cell transplant for cancer may help doctors plan treatment.

### [Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer](https://www.clareohealth.com/clinical-trials/NCT00104923)

Status: COMPLETED · Phase: PHASE1 · NCT00104923 · Los Angeles, California and 3 others · Sponsor: California Cancer Consortium

RATIONALE: Drugs used in chemotherapy, such as fenretinide, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing…

### [Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy](https://www.clareohealth.com/clinical-trials/NCT00890747)

Status: COMPLETED · Phase: PHASE1 · NCT00890747 · Los Angeles, California and 10 others · Sponsor: National Cancer Institute (NCI)

This phase I trial studies the side effects and the best dose of sunitinib malate in treating human immunodeficiency virus (HIV)-positive patients with cancer receiving antiretrovi…

### [Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation](https://www.clareohealth.com/clinical-trials/NCT00079222)

Status: COMPLETED · Phase: NA · NCT00079222 · Los Angeles, California · Sponsor: Jonsson Comprehensive Cancer Center

RATIONALE: Antifungals, such as voriconazole and itraconazole, may be effective in preventing fungal infections in patients who are undergoing allogeneic stem cell transplantation.

### [A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs](https://www.clareohealth.com/clinical-trials/NCT02200380)

Status: TERMINATED · Phase: PHASE2 · NCT02200380 · Los Angeles, California and 7 others · Sponsor: Celldex Therapeutics

This is an open-label, multicenter, prospective pilot study of CDX-301 with or without plerixafor as a stem cell mobilizer for allogeneic transplantation (stem cells that come from…

### [Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer](https://www.clareohealth.com/clinical-trials/NCT00002504)

Status: COMPLETED · Phase: PHASE2 · NCT00002504 · Newport Beach, California and 4 others · Sponsor: Hoag Memorial Hospital Presbyterian

RATIONALE: Interleukin-2 may stimulate a person's white blood cells to kill metastatic cancer cells. Interferon alfa may interfere with the growth of the cancer cells.

### [INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease](https://www.clareohealth.com/clinical-trials/NCT01164163)

Status: COMPLETED · Phase: PHASE1 · NCT01164163 · Birmingham, Alabama and 23 others · Sponsor: Children's Oncology Group

RATIONALE: INCB18424 (Ruxolitinib) may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

### [Decitabine in Treating Patients With Melanoma or Other Advanced Cancer](https://www.clareohealth.com/clinical-trials/NCT00002980)

Status: COMPLETED · Phase: PHASE1 · NCT00002980 · Duarte, California and 3 others · Sponsor: California Cancer Consortium

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

### [Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells](https://www.clareohealth.com/clinical-trials/NCT01050764)

Status: TERMINATED · Phase: PHASE1/PHASE2 · NCT01050764 · Stanford, California · Sponsor: Everett Meyer

Patients with hematologic malignancies will receive myeloablative chemotherapy followed by stem cell rescue with bone marrow or hematopoietic peripheral blood stem cells collected…

### [Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia](https://www.clareohealth.com/clinical-trials/NCT00933985)

Status: TERMINATED · Phase: PHASE1 · NCT00933985 · Birmingham, Alabama and 19 others · Sponsor: National Cancer Institute (NCI)

This phase I trial is studying the side effects and best dose of obatoclax mesylate when given together with vincristine sulfate, doxorubicin hydrochloride, and dexrazoxane hydroch…

### [Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation](https://www.clareohealth.com/clinical-trials/NCT00003056)

Status: TERMINATED · Phase: PHASE3 · NCT00003056 · Los Angeles, California and 12 others · Sponsor: Baxalta now part of Shire

RATIONALE: Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by chemotherapy or radiation therapy used to kill tumor cells.

## Leukemia Trials in Other Cities

- [New York](https://www.clareohealth.com/clinical-trials/condition/leukemia/new-york)
- [Los Angeles](https://www.clareohealth.com/clinical-trials/condition/leukemia/los-angeles)
- [Chicago](https://www.clareohealth.com/clinical-trials/condition/leukemia/chicago)
- [Houston](https://www.clareohealth.com/clinical-trials/condition/leukemia/houston)
- [Phoenix](https://www.clareohealth.com/clinical-trials/condition/leukemia/phoenix)
- [Philadelphia](https://www.clareohealth.com/clinical-trials/condition/leukemia/philadelphia)

## Other Conditions in California

- [Breast Cancer](https://www.clareohealth.com/clinical-trials/condition/breast-cancer/california)
- [Lung Cancer](https://www.clareohealth.com/clinical-trials/condition/lung-cancer/california)
- [Prostate Cancer](https://www.clareohealth.com/clinical-trials/condition/prostate-cancer/california)
- [Colorectal Cancer](https://www.clareohealth.com/clinical-trials/condition/colorectal-cancer/california)
- [Melanoma](https://www.clareohealth.com/clinical-trials/condition/melanoma/california)
- [Lymphoma](https://www.clareohealth.com/clinical-trials/condition/lymphoma/california)

Data from [ClinicalTrials.gov](https://clinicaltrials.gov).

---

## Sitemap

This is the Markdown version of https://www.clareohealth.com/clinical-trials/condition/leukemia/california.

- [Home](https://www.clareohealth.com/index.md)
- [About](https://www.clareohealth.com/about.md)
- [Pricing](https://www.clareohealth.com/pricing.md)
- [For providers](https://www.clareohealth.com/providers.md)
- [FAQ](https://www.clareohealth.com/faq.md)
- [Blog](https://www.clareohealth.com/blog.md)
- [Clinical trials](https://www.clareohealth.com/clinical-trials.md)
- [Developers](https://www.clareohealth.com/developers.md)
- [Privacy policy](https://www.clareohealth.com/legal/privacy-policy.md)
- [Terms of service](https://www.clareohealth.com/legal/terms-of-service.md)
- [Every page](https://www.clareohealth.com/sitemap.md)
- [About this site, for agents](https://www.clareohealth.com/llms.txt)
